EP 4192444 A1 20230614 - AMINOACIDS FOR TREATMENT OF NEUROLOGICAL DISORDERS
Title (en)
AMINOACIDS FOR TREATMENT OF NEUROLOGICAL DISORDERS
Title (de)
AMINOSÄUREN ZUR BEHANDLUNG VON NEUROLOGISCHEN ERKRANKUNGEN
Title (fr)
ACIDES AMINÉS DESTINÉS AU TRAITEMENT DE TROUBLES NEUROLOGIQUES
Publication
Application
Priority
- EP 2020071903 W 20200804
- EP 2021071785 W 20210804
Abstract (en)
[origin: WO2022029184A1] There is provided a composition for use in a therapeutic method of treatment of a subject suffering from a neurological disorder, said composition comprising: A) serine, glycine, betaine, N-acetylglycine, N-acetylserine, dimethylglycine, sarcosine and/or phosphoserine; B) N-acetyl cysteine, cysteine and/or cystine; C) carnitine, deoxycarnitine, gamma-butyrobetaine, 4- trimethylammoniobutanal, 3-hydroxy-N 6,N6,N 6-trimethyl-L-lysine, N6,N6,N6-trimethyl-L-lysine and/or lysine; and D) nicotinamide.
IPC 8 full level
A61K 31/195 (2006.01); A61K 31/198 (2006.01); A61K 31/661 (2006.01); A61K 31/7008 (2006.01); A61K 31/7084 (2006.01); A61P 25/28 (2006.01)
CPC (source: EP KR US)
A61K 31/195 (2013.01 - EP); A61K 31/198 (2013.01 - EP KR US); A61K 31/205 (2013.01 - KR US); A61K 31/455 (2013.01 - KR US); A61K 31/661 (2013.01 - EP KR); A61K 31/7008 (2013.01 - EP); A61K 31/7084 (2013.01 - EP); A61P 25/00 (2017.12 - KR); A61P 25/28 (2017.12 - EP KR US); A61K 2300/00 (2013.01 - KR)
C-Set (source: EP)
Citation (search report)
See references of WO 2022029184A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2022029184 A1 20220210; AU 2021322886 A1 20230413; CA 3192866 A1 20220210; EP 4192444 A1 20230614; KR 20230061400 A 20230508; US 2023270704 A1 20230831; WO 2022028678 A1 20220210
DOCDB simple family (application)
EP 2021071785 W 20210804; AU 2021322886 A 20210804; CA 3192866 A 20210804; EP 2020071903 W 20200804; EP 21759264 A 20210804; KR 20237007874 A 20210804; US 202118006479 A 20210804